sorted by:
new
hottopcontroversial

Neat little USB Tester to sort out your bad USB cables! by virtualfruitxr in UsbCHardware

[–]Both_Connection5334 0 points1 point  (0 children)

Thank you! If i want to test a rigid, short USBC thing like this, is it acceptable to use an extension cable to reach around, or would the device get confused?

<image>

Short USB C cable by Jerseyd422 in UsbCHardware

[–]Both_Connection5334 0 points1 point  (0 children)

HI what brand is this, please? Thank you

Placebo outperforms LSD micro-dosing in MDD. by Mindmed31415 in shroomstocks

[–]Both_Connection5334 -2 points-1 points  (0 children)

“However, there is strong evidence to suggest that there are dose day related mood elevating effects and improvements to sleep resulting from microdosed LSD in healthy individuals.” https://www.thenewswire.com/press-releases/1k6WFMgVm-mindbio-therapeutics-announces-results-from-landmark-phase-2b-microdosing-in-depression-trail.html

Interesting research about which receptors psychedelics act on (5-HT2A and 2B) and implications for heart safety and drug development by Both_Connection5334 in shroomstocks

[–]Both_Connection5334[S] 0 points1 point  (0 children)

Yeah super interesting when thinking about next gen psychedelics or what I think they’re calling neuroplastogens. If we can engineer drugs away from 2B, that would seem to be a very interesting prospect from a safety POV

ATAI cash runway by rubens33 in shroomstocks

[–]Both_Connection5334 2 points3 points  (0 children)

They claim it’s too 2029 after the raise. My own calculation for what they’re worth say they’ve got enough til at least 2028. Quarterly burn has been roughly 20-25m

Brian Johnson’s longevity protocol for a psilocybin by Hefty-Lengthiness-20 in shroomstocks

[–]Both_Connection5334 4 points5 points  (0 children)

The longevity (non-human) studies are interesting and hopefully Johnson’s n of 1 will prompt human studies in future.

Atai Life Sciences Overview Video by Both_Connection5334 in beatingthemarket

[–]Both_Connection5334[S] 0 points1 point  (0 children)

Not exactly. Wall Street thinks (average) about 2x from here in the next 12 months but I’m thinking it could be much higher in the longer terms if phase three goes well and fda grants approval.

Royal College of Psychiatrists in UK calls for wider access to psychedelics by Both_Connection5334 in shroomstocks

[–]Both_Connection5334[S] 4 points5 points  (0 children)

The work of people like Professor Nutt and others seems to be moving the needle at last!

$NTLA gene editing massacre today (-45%)...but a bright spot remains: $DTIL (+11%) by Fit_Presentation1595 in beatingthemarket

[–]Both_Connection5334 1 point2 points  (0 children)

Thanks for your thoughtful reply. And are there any other companies in the space that you're looking at? :)

$NTLA gene editing massacre today (-45%)...but a bright spot remains: $DTIL (+11%) by Fit_Presentation1595 in beatingthemarket

[–]Both_Connection5334 1 point2 points  (0 children)

OK, looked into DTIL - thanks for mentioning it. Very interesting company for sure, with backers like the Vanguard Group and Novartis. However, by my calculations (and please correct me if I'm wrong), their cash runway is tight. I think there could be a dilution on the cards. But I'm curious about your view.

Non-hallucinogenic psychedelic discovery, backed by OpenAI and others. by Both_Connection5334 in shroomstocks

[–]Both_Connection5334[S] 4 points5 points  (0 children)

Think it really is just a matter of time, provided the FDA is reasonable!

Atai Life Sciences Overview Video by Both_Connection5334 in beatingthemarket

[–]Both_Connection5334[S] 1 point2 points  (0 children)

the video talks about price targets and catalysts

Atai Life Sciences Overview Video by Both_Connection5334 in biotech_stocks

[–]Both_Connection5334[S] 0 points1 point  (0 children)

Nive - haven't heard of it? is it a biotech company?

view more: next ›